tiprankstipranks
Virax Biolabs Pops On Launch of Virus Antigen Rapid Test Kit
Market News

Virax Biolabs Pops On Launch of Virus Antigen Rapid Test Kit

Shares of Virax Biolabs (NASDAQ: VRAX) popped in morning trading on Thursday after the biotechnology company announced the launch and distribution of an RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit in markets like the European Union (EU), which accept the CE mark.

Pick the best stocks and maximize your portfolio:

The test kits are for use in both at-home and in point-of-care settings with results usually available in 15 minutes.

Go Ad-Free with Our App